-
Which critical medicines are in short supply in the European Union?
11 Mar 2025 23:20 GMT
… urge doctors to transition their patients to other brands.
Seven cancer drugs … 2025.
Blood disease medicine
Peginterferon alfa-2a, sold as Pegasys, is used … , leaving the medicine in short supply, though other treatments are available. Limited …
-
Pegasys Copegus Combination Pack Market Report 2025: Global Market Size, Key Trends, Growth Insights, and Forecast
10 Mar 2025 15:53 GMT
… injectable treatments.
• Increased adoption of personalized medicine for … injectable drug use.
• Poor sterilization practices in medical facilities. … 47;report/pegasys-copegus-combination-pack- … among other major pharmaceutical companies. Their continued …
-
Pegasys Market Forecast 2025-2034: Comprehensive Insights On Market Size, Growth Factors, And Trends
10 Mar 2025 13:15 GMT
… approvals supporting Pegasys use
o Inclusion in treatment guidelines
o … acting antivirals alongside Pegasys
o Shift toward personalized treatment approaches
o … new hepatitis treatments
o Continued regulatory support for Pegasys
Additionally, the …
-
PharmaEssentia Highlights Availability of BESREMi® (ropeginterferon alfa-2b-njft) for Patients Affected by Pegasys® (peginterferon alfa-2a) Drug Shortage
04 Mar 2025 16:31 GMT
… as an ongoing Pegasys® shortage poses challenges in treatment continuity. By … and Drug Administration (FDA) in 2021, and by the Pharmaceuticals and Medical Devices … scientists from U.S. biotechnology and pharmaceutical companies, today PharmaEssentia is …
-
B-Together Trial Demonstrates Efficacy of Bepirovirsen Followed By Peg-IFN for HBV
24 Feb 2025 19:58 GMT
… treatment featuring bepirovirsen followed by 24 weeks of peginterferon (Peg-IFN, Pegasys … chronic HBV infection.2 The trial was conducted from January 28 … Pharmaceuticals, Novartis).1,2
Patients were randomly assigned to either treatment arm …
-
Global Pegasys Copegus Market Forecast: Key Growth Drivers, Trends, and Opportunities from 2025 to 2034
30 Jan 2025 18:04 GMT
… the adoption of personalized medicine in hepatitis treatment, increased healthcare spending in … significant role in boosting the Pegasys Copegus Combination Pack market … drugs, inadequate sterilization practices in healthcare settings, the reuse of medical …
-
The Pegasys Global Market Report 2025: Insightful Analysis of Market Size, Growth Drivers, Share, and Emerging Trends
30 Jan 2025 17:30 GMT
… -acting antivirals alongside pegasys, a growing focus on personalized treatment approaches, rising … into new hepatitis treatments, and ongoing regulatory support for pegasys.
The increasing …
-
Global Pegasys Copegus Market Forecast: Key Growth Drivers, Trends, and Opportunities from 2025 to 2034
29 Jan 2025 17:42 GMT
… the adoption of personalized medicine in hepatitis treatment, increased healthcare spending in … significant role in boosting the Pegasys Copegus Combination Pack market … drugs, inadequate sterilization practices in healthcare settings, the reuse of medical …
-
The Pegasys Global Market Report 2025: Insightful Analysis of Market Size, Drivers, Key Players, and Emerging Trends
29 Jan 2025 17:19 GMT
… -acting antivirals alongside pegasys, a growing focus on personalized treatment approaches, rising … into new hepatitis treatments, and ongoing regulatory support for pegasys.
The increasing …
-
9 drugs in shortage
28 Jan 2025 17:15 GMT
… is used in oncology treatments. The decision is based … reported a shortage of Pegasys injection, which is used … hydrochloride tablets, a medication used to treat depression … to the FDA.
Verapamil hydrochloride capsule: Teva Pharmaceuticals has discontinued …